Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
Sponsor: Stephen Nicholls • ClinicalTrials.gov ID: NCT05325034
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
Multinational, patient-level randomised, multi-phase standard-of-care control arm, parallel group, implementation study. Patients will be recruited during hospitalisation and be randomised to a multifaceted intervention to be delivered either 'early' (baseline) or 'late' (6 months), in a 1:1 fashion.
Interventions
-
Early Intervention
(Behavioral)
Participant and clinician lipid score card to increase the likelihood of effecting guideline-directed change in lipid lowering therapy through two key actors - both the patient and their clinician(s). The Score Card documents four key fields to be completed by the participant, study team and participant's regular clinician including 1) 'current' LDL-C level, 2) participant's level of adherence to lipid-lowering therapy using modified Voil's criteria, 3) lipid-lowering management decisions made at the clinician's appointment and 4) currently prescribed lipid-lowering therapies.
Eligibility criteria
Conditions
Locations
- Illawarra Shoalhaven Local Health District — Wollongong, New South Wales, Australia
- Cairns & Hinterland Hospital & Health Service — Cairns, Queensland, Australia
- Flinders Medical Centre — Bedford Park, South Australia, Australia
- Monash Health — Clayton, Victoria, Australia
- Western Health — Melbourne, Victoria, Australia
- Affiliated Zhongshan Hospital of Dalian University — Dalian, Liaoning, China
- All India Institute of Medical Sciences — New Delhi, India
- Fukuoka University Hospital — Fukuoka, Japan
- Kyorin University Hospital — Mitaka, Japan
- National Cerebral and Cardiovascular Center — Osaka, Japan
- Osaka Medical and Pharmaceutical University Hospital — Osaka, Japan
- University Teknologi MARA, Hospital UiTM, UiTM Medical Centre — Shah Alam, Selangor, Malaysia
- National Heart Institute — Kuala Lumpur, Malaysia
- University of Malaysia Medical Centre — Kuala Lumpur, Malaysia
- National Heart Centre — Singapore, Singapore
- National University Hospital Singapore (NUHS) — Singapore, Singapore
- PyeongChon Hallym University Sacred Heart Hospital — Pyeongchon, Gyeonggi Province, South Korea
- Kangnam Hallym University Sacred Heart Hospital — Seoul, South Korea
- National Cheng Kung University Hospital — Tainan, Taiwan
- Siriraj Hospital — Bangkok, Thailand
- Srinagarind Hospital and Queen Sirikit Heart Center of the Northeast — Khon Kaen, Thailand
- Songklanagarind Hospital — Songkhla, Thailand
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record